References
- Adibhatla RM, Hatcher JF, Dempsey RJ. (2001). Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke 32: 2376–2381.
- Aune TM, Pogue SL. (1989). Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J Clin Invest 84: 863–875.
- Barrachina M, Dominguez I, Ambrosio S, Secades J, Lozano R, Ferrer I. (2003). Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells. J Neurol Sci 215: 105–110.
- Basu A, Som A, Ghoshal S, Mondal L, Chaubey RC, Bhilwade HN, Rahman MM, Giri AK. (2005). Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal, India. Toxicol Lett 159: 100–112.
- Das AK, Sahu R, Dua TK, Bag S, Gangopadhyay M, Sinha MK, Dewanjee S. (2010). Arsenic-induced myocardial injury: protective role of Corchorus olitorius leaves. Food Chem Toxicol 48: 1210–1217.
- Fioravanti M, Yanagi M. (2000). Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 4: 2.CD000269.
- Flora SJ. (2011). Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51: 257–281.
- Foyer CH, Noctor G. (2005). Oxidant and antioxidant signalling in plants: a re-evaluation of the concept of oxidative stress in a physiological context. Plant, Cell & Environment 28: 1056–1071.
- González-Pacheco H, Méndez-Domínguez A, Hernández S, López-Marure R, Vazquez-Mellado MJ, Aguilar C, Rocha-Zavaleta L. (2014). Pre-conditioning with CDP-choline attenuates oxidative stress-induced cardiac myocyte death in a hypoxia/reperfusion model. Scientific World Journal 2014: 187071.
- Harris GK, Shi X. (2003). Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res 533: 183–200.
- Hoonjan M, Jadhav V, Bhatt P. (2018). Arsenic trioxide: insights into its evolution to an anticancer agent. J Biol Inorg Chem 23: 313–329.
- Krupinski J, Abudawood M, Matou-Nasri S, Al-Baradie R, Petcu EB, Justicia C, Planas A, Liu D, Rovira N, Grau-Slevin M, Secades J. (2012). Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc Cell 4: 20.
- Kumazaki M, Ando H, Sasaki A, Koshimizu TA, Ushijima K, Hosohata K, Oshima Y, Fujimura A. (2011). Protective effect of α-lipoic acid against arsenic trioxide–induced acute cardiac toxicity in rats. J Pharmacol Sci 115: 244–248.
- Kwong YL, Todd D. (1997). Delicious poison: arsenic trioxide for the treatment of leukemia. Blood 89: 3487–3488.
- Liu Z, Carbrey JM, Agre P, Rosen BP. (2004). Arsenic trioxide uptake by human and rat aquaglyceroporins. Biochem Biophys Res Commun 316: 1178–1185.
- Martinet M, Fonlupt P, Pacheco H. (1979). Effects of cytidine-5’diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain. Arch Int Pharmacodyn Ther 239: 52–61.
- Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG. (1989). Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263: 539–545.
- Méndez-Gómez J, García-Vargas GG, López-Carrillo L, Calderón-Aranda ES, Gómez A, Vera E, Valverde M, Cebrián ME, Rojas E. (2008). Genotoxic effects of environmental exposure to arsenic and lead on children in region Lagunera, Mexico. Ann N Y Acad Sci 1140: 358–367.
- Pei Q, Ma N, Zhang J, Xu W, Li Y, Ma Z, Li Y, Tian F, Zhang W, Mu J, Li Y. (2013). Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions. Toxicol Appl Pharmacol 266: 143–149.
- Putignano S, Gareri P, Castagna A, Cerqua G, Cervera P, Cotroneo AM, Fiorillo F, Grella R, Lacava R, Maddonni A, Marino S. (2012). Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clin Interv Aging 7: 113–118.
- Qian K, Gu Y, Zhao Y, Li Z, Sun M. (2014). Citicoline protects brain against closed head injury in rats through suppressing oxidative stress and calpain over-activation. Neurochem Res 39: 1206–1218.
- Ratnaike RN. (2003). Acute and chronic arsenic toxicity. Postgrad Med J 79: 391–396.
- Reiter RJ. (1998). Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56: 359–384.
- Salehpour F, Aghazade J, Mirzaee F, Mahdkhah A. (2015). Citicoline in patients with traumatic brain injuries. EC Neurology 2: 87–93.
- Sampayo-Reyes A, Hernández A, El-Yamani N, López-Campos C, Mayet-Mach-ado E, Rincón-Castañeda CB, Limones-Aguilar MD, López-Campos JE, de León MB, González-Hernández S, Hinojosa-Garza D. (2010). Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicol Sci 117: 63–71.
- Secades JJ, Frontera G. (1995). CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol 17: 1–54.
- Shaughnessy SG, Buchanan MR, Turple S, Richardson M, Orr FW. (1989). Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am J Pathol 134: 787–796.
- Szatrowski TP, Nathan CF. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794–798.
- Vineetha VP, Girija S, Soumya RS, Raghu KG. (2014). Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity. Food Funct 5: 502–511.
- Waxman S, Anderson KC. (2001). History of the development of arsenic derivatives in cancer therapy. Oncologist 6:3–10.
- Wu MM, Chiou HY, Wang TW, Hsueh YM, Wang IH, Chen CJ, Lee TC. (2001). Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect 109: 1011–1017.
- Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y, Yang B. (2008). Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol 102: 419–425.